Business Growth Analysis Of U.S. General Anesthesia Drugs Market
U.S. General Anesthesia Drugs Market categories the Global by route of administration (Intravenous, Inhalational), Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), Competitive & by Geography
(EMAILWIRE.COM, August 12, 2018 ) According to a new market research report "U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020", published by MarketsandMarkets, The U.S. General Anesthesia Drugs Market is expected to reach around $2 Billion by 2020 at a CAGR of 3.8% from 2015 to 2020.
Browse 42 market data Tables and 28 Figures spread through 114 Pages and in-depth TOC on "U.S. General Anesthesia Drugs Market"
<||>rnhttp://www.marketsandmarkets.com/Market-Reports/anesthesia-drugs-ketamine-market-713.html
On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is expected to account for the largest share of the market in 2015. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of this market.
Growth of the U.S. general anesthesia drugs market is propelled by the rapid rise in aging population, rising prevalence of cardiovascular and respiratory system-related diseases, and rising number of emergency surgeries. However, side effects associated with ketamine usage (such as elevation in blood pressure and heart rate, amnesia, respiratory depression, and hallucinations), regulatory issues, and lower compliance rates in comparison with other anesthetic drugs are likely to restrain the growth of this market.
Key players operating in the U.S. general anesthesia drugs market are AstraZeneca plc (U.K.), Baxter International Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Mylan N.V. (U.S.), Eisai Co., Ltd. (Japan), Fresenius Se & Co. KGaA (Germany), Hospira, Inc. (U.S.), and Par Pharmaceutical Companies, Inc. (U.S.).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=713
Browse 42 market data Tables and 28 Figures spread through 114 Pages and in-depth TOC on "U.S. General Anesthesia Drugs Market"
<||>rnhttp://www.marketsandmarkets.com/Market-Reports/anesthesia-drugs-ketamine-market-713.html
On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is expected to account for the largest share of the market in 2015. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of this market.
Growth of the U.S. general anesthesia drugs market is propelled by the rapid rise in aging population, rising prevalence of cardiovascular and respiratory system-related diseases, and rising number of emergency surgeries. However, side effects associated with ketamine usage (such as elevation in blood pressure and heart rate, amnesia, respiratory depression, and hallucinations), regulatory issues, and lower compliance rates in comparison with other anesthetic drugs are likely to restrain the growth of this market.
Key players operating in the U.S. general anesthesia drugs market are AstraZeneca plc (U.K.), Baxter International Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Mylan N.V. (U.S.), Eisai Co., Ltd. (Japan), Fresenius Se & Co. KGaA (Germany), Hospira, Inc. (U.S.), and Par Pharmaceutical Companies, Inc. (U.S.).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=713
Contact Information:
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results